Position in SPRY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,231,505
-$28,811,334 QoQ
Shares Held
2,400,937
-59.9% QoQ
Ownership
2.41%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#12
of 208 holders
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Derivatives in SPRY
reported options exposure · as of Jun 30, 2026CallValue
$961,200
CallShares
120,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. SPRY ranks #53 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in SPRY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,231,505 | 2,400,937 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $961,200 | 120,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $48,042,839 | 5,982,919 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $36,911,929 | 3,168,406 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $15,323,839 | 878,157 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,152,512 | 807,036 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,909,382 | 939,278 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,057,817 | 486,746 | Shares | Sole | 2024-11-14 | |
| 2023-09-30 | $4,148,644 | 1,097,525 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $203,742 | 53,900 | Put | Sole | 2023-11-14 | |
| 2023-06-30 | $8,036,355 | 1,199,456 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $502,500 | 75,000 | Put | Sole | 2023-08-14 | |
| 2023-03-31 | $1,623,672 | 249,412 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $270,409 | 31,701 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,844,198 | 349,280 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,929,416 | 455,051 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $3,964,424 | 595,259 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $9,517,836 | 953,691 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $278,936 | 9,030 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,603,489 | 36,752 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,694,247 | 166,039 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||